Evidence map›Paper›PMID 28643016›Full record

ArticleFamilial cancer2018

Screening for Lynch syndrome in young Saudi colorectal cancer patients using microsatellite instability testing and next generation sequencing.

Masood Alqahtani, Caitlin Edwards, Natasha Buzzacott, Karen Carpenter, Khalid Alsaleh, Abdulmalik Alsheikh, Waleed Abozeed, Miral Mashhour, Afnan Almousa, Yousef Housawi and 2 more

Abstract read
PubMed Publisher
In one paragraph

Article in Familial cancer, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.4field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 3 countries.

Masood AlqahtaniFaculty of Health and Medical Sciences, School of Biomedical Sciences, University of Western Australia, Nedlands, Australia.
Caitlin EdwardsDepartment of Diagnostic Genomics, PathWest, Nedlands, Australia.
Natasha BuzzacottDepartment of Diagnostic Genomics, PathWest, Nedlands, Australia.
Karen CarpenterDepartment of Diagnostic Genomics, PathWest, Nedlands, Australia.
Khalid AlsalehCollege of Medicine, King Saud University Medical City, King Saud University, Riyadh, Saudi Arabia.
Abdulmalik AlsheikhCollege of Medicine, King Saud University Medical City, King Saud University, Riyadh, Saudi Arabia.
Waleed AbozeedCollege of Medicine, King Saud University Medical City, King Saud University, Riyadh, Saudi Arabia.
Miral MashhourDepartment of Pathology and Laboratory Medicine, Department of Genetics, King Fahad Specialist Hospital-Dammam, Dammam, Saudi Arabia.
Afnan AlmousaDepartment of Pathology and Laboratory Medicine, Department of Genetics, King Fahad Specialist Hospital-Dammam, Dammam, Saudi Arabia.
Yousef HousawiDepartment of Pathology and Laboratory Medicine, Department of Genetics, King Fahad Specialist Hospital-Dammam, Dammam, Saudi Arabia.
Shareefa Al HawwajDepartment of Pathology and Laboratory Medicine, Department of Genetics, King Fahad Specialist Hospital-Dammam, Dammam, Saudi Arabia.
Barry IacopettaFaculty of Health and Medical Sciences, School of Biomedical Sciences, University of Western Australia, Nedlands, Australia. barry.iacopetta@uwa.edu.au.
King Fahad Specialist Hospital · SAPathwest Laboratory Medicine · AUKing Saud University · SAUniversity of Western Australia · AUMansoura University · EG

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Individuals with Lynch syndrome (LS) have germline variants in DNA mismatch repair (MMR) genes that confer a greatly increased risk of colorectal cancer (CRC), often at a young age. Identification of these individuals has been shown to increase their survival through improved surveillance. We previously identified 33 high risk cases for LS in the Saudi population by screening for microsatellite instability (MSI) in the tumor DNA of 284 young CRC patients. The aim of the present study was to identify MMR gene variants in this cohort of patients. Peripheral blood DNA was obtained from 13 individuals who were at high risk of LS due to positive MSI status and young age (<60 years at diagnosis). Next generation sequencing, Sanger sequencing and Multiplex Ligation-dependent Probe Amplification were used to screen for germline variants in the MLH1, MSH2, MSH6 and PMS2 MMR genes. These were cross-referenced against several variant databases, including the International Society for Gastrointestinal Hereditary Tumors Incorporated database. Variants with pathogenic or likely pathogenic significance were identified in 8 of the 13 high risk cases (62%), comprising 4 in MLH1 and 4 in MSH2. All carriers had a positive family history for CRC or endometrial cancer. Next generation sequencing is an effective strategy for identifying young CRC patients who are at high risk of LS because of positive MSI status. We estimate that 7% of CRC patients aged <60 years in Saudi Arabia are due to LS, potentially involving around 50 new cases per year.

Indexed as

Genetic Predisposition to DiseaseMicrosatellite InstabilityAdultBiomarkers, TumorCohort StudiesColorectal Neoplasms, Hereditary NonpolyposisDNA Mismatch RepairEarly Detection of CancerFemaleGenetic TestingHigh-Throughput Nucleotide SequencingHumansIncidenceMaleMiddle AgedMutL Protein Homolog 1Biomarkers, TumorMLH1 protein, humanMSH2 protein, humanMutL Protein Homolog 1MutS Homolog 2 ProteinColorectal cancerLynch syndromeMicrosatellite instabilitySaudiScreening

Identifiers

PMID28643016
OpenAlexW2695579828

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.